Immunology

Taming the chaotic protein that fuels cancers

MYC is a protein that it is claimed is responsible for making the majority of human cancer cases worse.

Tissue grafts that escape immune system rejection

In a preclinical breakthrough, researchers have developed a technology that may one day eliminate the need for immunosuppressive drugs in transplant patients.

Fractional COVID-19 booster vaccines

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study.

How to measure improvement in long COVID

Researchers have reached an agreement on how to measure the severity and impact of long COVID by identifying a “Core Outcome Measure Set” (COMS).

Benefits of exercise and the immune system

A new study may offer molecular insights into the connection between exercise and inflammation.

HIV and the “art” of understanding

Biomedical Scientist Carl Onwochei on why we need to stay informed, challenge misinformation and be open to discussion.

Mechanisms of alarming release discovered

Scientists have demonstrated that important pro-inflammatory mediators are released into the bloodstream through tiny pores in the cell membrane at a very early stage of an immune response.

New vaccine against malaria

The World Health Organization (WHO) has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children.

Why didn’t people in the US get COVID-19 boosters?

More than 80% of the people in the US who were eligible to receive a COVID-19 booster last autumn did not have the jab.

Suppressing autoimmunity

Researchers have uncovered new details about how the immune system prevents the production of antibodies that can recognise and damage healthy tissues.

Unparalleled depth of data

Professor of Respiratory Research Louise Wain discusses an ongoing research project into the medium- and long-term effects of COVID.

Top